RYCFX Mutual Fund
RYCFX Mutual Fund
RYCFX Mutual Fund
Rydex Biotechnology Fund Class C
RYCFX Mutual Fund Overview
RYCFX Mutual Fund (Rydex Biotechnology Fund Class C) is managed by Rydex Funds with $432,570.36 in net assets. RYCFX expense ratio is 2.38%, holding 69 positions across sectors including Health Care. Inception date: 2001-03-30.
RYCFX performance shows a YTD return of 14.54%. The 1-year return is 45.96% and the 5-year return is 4.67%. RYCFX dividend yield stands at 18.98%, paid annually.
RYCFX top holdings include Abbvie Inc. (7.6%), Amgen Inc. (5.1%), Gilead Sciences (4.7%), Nvaesrtex Pharmaceuticals Inc (4.0%), Regeneron Pharmaceuticals, Inc. (2.9%). Go to all RYCFX holdings, RYCFX sectors, or RYCFX dividends.
RYCFX can be compared against other funds. Use RYCFX overlap to find shared positions, or RYCFX vs another fund for a side-by-side view. RYCFX alternatives are available via the screener, along with tax-loss harvesting opportunities.